YALDOO LAITH L 4
Research Summary
AI-generated summary
Zivo Bioscience 10% Owner Laith L. Yaldoo Buys 1,766 Shares
What Happened
Laith L. Yaldoo, reported as a 10% owner of Zivo Bioscience (ZIVO), purchased 1,766 shares on January 14, 2026. The shares were acquired at $8.49 per share for a total reported value of $14,993. The transaction is reported as a purchase (Form 4 code P) and was listed as an open-market or private purchase.
Key Details
- Transaction date: 2026-01-14; Price: $8.49 per share; Shares purchased: 1,766; Total value: $14,993.
- Filing date: 2026-01-27 — 13 days after the trade (past the typical 2-business-day Form 4 reporting deadline).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnotes/plans: none noted in the provided data (no 10b5-1 plan, tax withholding, or other special notations reported).
Context
A direct purchase by a 10% owner is a straightforward buy rather than an option exercise or gift and can be more informative to investors than routine sell activity. Note that 10% owners are large shareholders rather than necessarily executive trading; filings from such owners signal a substantial holder changing position. The late filing reduces the immediacy of the disclosure—Form 4s are generally required within two business days of the transaction—so investors should consider timing when interpreting this signal.